Earlier this year, Healthware Group and Plexus Ventures formed an alliance to structure deals for the pharmaceutical industry in the development and commercialization of Digital Therapeutic (DTx) products. Given the increased attention and growth seen in the market, both companies are leveraging their expertise to become go-to partners for life sciences companies looking to incorporate DTx into their pipelines.
Join us to learn about the evolution of deal-making in pharma, evolving from molecules to software. We will discuss what is happening at the intersection between pharma and DTx companies. How are they interacting with each other? What kind of partnerships are shaping the market? What are the key value drivers?
